Abstract:Background: Irritable bowel syndrome (IBS) is the most prevalent gastrointestinal disorder in developed countries and reduces patients' quality of life, hinders their ability to work, and increases health care costs. A growing number of trials have demonstrated an aberrant gut microbiota composition in IBS, also known as 'gut dysbiosis'. Fecal microbiota transplantation (FMT) has been suggested as a treatment for IBS. Aim: To assess the efficacy and safety of FMT for the treatment of IBS. Methods: We searched Cochrane Central, MEDLINE, EMBASE and Web of Science up to 24 October 2022 for randomised controlled trials (RCTs) investigating the effectiveness of FMT compared to placebo (including autologous FMT) in treating IBS. The primary outcome was the number of patients with improvements of symptoms measured using a validated, global IBS symptoms score. Secondary outcomes were changes in quality-of-life scores, non-serious and serious adverse events. Risk ratios (RR) and corresponding 95%CI were calculated for dichotomous outcomes, as were the mean differences (MD) and 95%CI for continuous outcomes. The Cochrane risk of bias tool was used to assess the quality of the trials. GRADE criteria were used to assess the overall quality of the evidence. Results: Eight RCTs (484 participants) were included in the review. FMT resulted in no significant benefit in IBS symptoms three months after treatment compared to placebo (RR 1.19, 95%CI: 0.68-2.10). Adverse events were reported in 97 participants in the FMT group and in 45 participants in the placebo group (RR 1.17, 95%CI: 0.63-2.15). One serious adverse event occurred in the FMT group and two in the placebo group (RR 0.42, 95%CI: 0.07-2.60). Endoscopic FMT delivery resulted in a significant improvement in symptoms, while capsules did not. FMT did not improve the quality of life of IBS patients but, instead, appeared to reduce it, albeit non significantly (MD -6.30, 95%CI: -13.39-0.79). The overall quality of the evidence was low due to moderate-high inconsistency, the small number of patients in the studies, and imprecision. Conclusion: We found insufficient evidence to support or refute the use of FMT for IBS. Larger trials are needed.

Psychological treatments for irritable bowel syndrome: a comprehensive systematic review and meta-analysis

Mind-body treatments of irritable bowel syndrome symptoms: An updated meta-analysis

The Efficacy of Vitamin D Supplementation for Irritable Bowel Syndrome: a Systematic Review with Meta-Analysis

Psychological Factors May Affect the Quality of Life in Irritable Bowel Syndrome Patients More Than the Gut Itself? A Multicenter Cross‐sectional Study

Home-based Cognitive Behavioural Therapy for Irritable Bowel Syndrome in Adults: A Meta-analysis

Psychotherapeutic Interventions in Irritable Bowel Syndrome

The Physiological and Psychological Effects of Cognitive Behavior Therapy on Patients with Inflammatory Bowel Disease Before COVID-19: a Systematic Review

Effect of Brain-gut Behavioral Treatments on Abdominal Pain in Irritable Bowel Syndrome: Systematic Review and Network Meta-analysis.

Aspects of the non-pharmacological treatment of irritable bowel syndrome

Gut-directed hypnosis and hypnotherapy for irritable bowel syndrome: a mini-review

The Effect of Polyphenols, Minerals, Fibers, and Fruits on Irritable Bowel Syndrome: A Systematic Review

Vitamin D Improves Irritable Bowel Syndrome Symptoms: A Meta-Analysis

Complementary and alternative medicine for treatment of irritable bowel syndrome

Exposure and mindfulness based therapy for irritable bowel syndrome--an open pilot study

Fecal microbiota transplantation for the treatment of irritable bowel syndrome: A systematic review and meta-analysis

Current state of the non‐pharmacological management of irritable bowel syndrome: an up‐to‐date review of the literature

Irritable bowel syndrome: treatment based on pathophysiology and biomarkers

Irritable Bowel Syndrome: Treating the Gut and Brain/Mind at the Same Time

Hypnotherapy for Irritable Bowel Syndrome-Type Symptoms in Patients with Quiescent Inflammatory Bowel Disease: A Randomized, Controlled Trial

Internet delivered exposure based cognitive behavior therapy for IBS – A clinical effectiveness study.

Nutritional Interventions in Adult Patients With Irritable Bowel Syndrome: An Umbrella Review of Systematic Reviews and Meta-analyses of Randomized Clinical Trials